Nov 19, 2026
Nuropod has released a new guide exploring the connection between fibromyalgia and the vagus nerve, examining how the nervous system processes pain and why noninvasive vagus nerve stimulation is attracting growing research interest.
Sacramento, United States, November 19, 2026 /PressCable/ -- Nuropod has released a new guide examining the connection between the vagus nerve and fibromyalgia, including how pain signals are processed and why researchers are studying vagus nerve stimulation in relation to symptoms such as widespread pain and fatigue.
More information is available at https://nuropod.com/blogs/articles/vagus-nerve-and-fibromyalgia-pain-symptoms-connection
Fibromyalgia affects approximately 4 million adults in the United States, or around 2% of the adult population, the Centers for Disease Control and Prevention (CDC) reports. The condition can involve chronic widespread pain, fatigue, sleep disturbances, and cognitive difficulties, creating challenges that extend beyond physical discomfort alone.
The new guide explores these symptoms before examining why the vagus nerve has become an area of research interest. It explains that fibromyalgia is associated with changes in how the nervous system processes pain signals, rather than necessarily indicating tissue damage in the areas where pain is felt. The vagus nerve connects the brain with organs including the heart, lungs, and gut and contributes to autonomic regulation.
The guide also examines research involving Parasym's proprietary AVNT™ technology. Across studies involving different populations, the company reports an average 38% reduction in widespread pain and a 48% reduction in fatigue.
Nuropod uses the same proprietary AVNT waveform in a wearable device that delivers noninvasive vagus nerve stimulation through an earpiece attached to the tragus. The company describes typical sessions of around 30 minutes, once or twice daily, allowing users to incorporate the device into activities such as reading, working, or relaxing at home.
Parasym says its research program includes more than 60 completed clinical studies, 100+ ongoing studies, and collaborations with over 150 research institutions, supported by more than 10 years of research and development. Nuropod is intended for use alongside existing care rather than as a replacement for treatments recommended by healthcare professionals.
To learn more about Nuropod's vagus nerve stimulation technology and the research behind it, visit https://nuropod.com
Disclaimer: Research referenced in this article was conducted using Parasym’s neuromodulation technology under research conditions. Findings relate to specific study populations and should not be interpreted as guaranteed individual outcomes. Nuropod is classified by the FDA as a non-significant risk device and is not intended to diagnose, treat, cure, or prevent any disease.
Contact Info:
Name: PR Team
Email: Send Email
Organization: Nuropod by Parasym
Address: 2108 N Street, Sacramento, California 95816, United States
Website: https://nuropod.com/
Source: PressCable
Release ID: 89210080
In case of detection of errors, concerns, or irregularities in the content provided in this press release, or if there is a need for a press release takedown, we strongly encourage you to reach out promptly by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will be at your disposal for immediate assistance within 8 hours – resolving identified issues diligently or guiding you through the removal process. We take great pride in delivering reliable and precise information to our valued readers.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.
Gillingham captain Liam Gordon’s return date has been delayed, but there’s better injury news ahead of Saturday.
Manager Gareth Ainsworth is keen to build on their weekend performance - even if the result added to growing frustration among the fans.
Catch up with all the week’s football fixtures and results.
Gillingham midfielder Zane Albarus reflects on a steep learning curve, including an early career red card.
Former Gillingham striker Adebayo Akinfenwa has backed his old boss Gareth Ainsworth to enjoy a successful season this time around.
The family of former Gillingham winger Jordan Graham have issued a positive update on his recovery from a serious road traffic accident.
Wicketkeeper Chris Benjamin has been praised by Kent captain Daniel Bell-Drummond as the 33-year-old also discusses all-rounder Ekansh Singh’s rise.
The Kent County Athletics Association’s President’s Awards raised a glass to some of the top performers of 2026.
Gillingham teenager Cruz Beszant showed what he's got in his locker after scoring a stunning 50-yard goal at the weekend.
Gillingham defender Omar Beckles insists the players are hurting as much as the fans after Saturday’s defeat at Colchester United.
Former County Championship-winning Kent and England bowler Alan Brown, who also enjoyed a prolific non-league football career, has died.